Phenotypic characterization identified CTC subpopulations with stemness characteristics after therapy and a post-therapeutic PD-L1+ CD49f+ CD133+ CTC subpopulation in the patients’ blood of both tumor entities was associated with reduced recurrence free survival. Here, PROM1 is linked to neoplasm.